These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31370220)

  • 21. Microbiota and prebiotics modulation of uremic toxin generation.
    Koppe L; Fouque D
    Panminerva Med; 2017 Jun; 59(2):173-187. PubMed ID: 28001024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Stability and Function of Probiotic
    Ma DX; Zhou Y; Wu LD; Li ZY; Jiang WJ; Huang SL; Guo XP; Sheng JZ; Wang FS
    ACS Appl Mater Interfaces; 2022 Sep; 14(38):42963-42975. PubMed ID: 36111385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.
    Vaziri ND; Zhao YY; Pahl MV
    Nephrol Dial Transplant; 2016 May; 31(5):737-46. PubMed ID: 25883197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiome in chronic kidney disease: challenges and opportunities.
    Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
    Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production.
    Kim MS; Byun JS; Yoon YS; Yum DY; Chung MJ; Lee JC
    Benef Microbes; 2017 Apr; 8(2):231-241. PubMed ID: 28008786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis.
    Thongprayoon C; Kaewput W; Hatch ST; Bathini T; Sharma K; Wijarnpreecha K; Ungprasert P; D'Costa M; Mao MA; Cheungpasitporn W
    Dig Dis Sci; 2019 Feb; 64(2):469-479. PubMed ID: 30099652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
    Yang CY; Tarng DC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review.
    Lopes RCSO; Balbino KP; Jorge MP; Ribeiro AQ; Martino HSD; Alfenas RCG
    Nutr Hosp; 2018 Apr; 35(3):722-730. PubMed ID: 29974784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut microbiota and its relationship with chronic kidney disease.
    Plata C; Cruz C; Cervantes LG; Ramírez V
    Int Urol Nephrol; 2019 Dec; 51(12):2209-2226. PubMed ID: 31576489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial.
    Borges NA; Carmo FL; Stockler-Pinto MB; de Brito JS; Dolenga CJ; Ferreira DC; Nakao LS; Rosado A; Fouque D; Mafra D
    J Ren Nutr; 2018 Jan; 28(1):28-36. PubMed ID: 28888762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
    Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
    J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.
    Koppe L; Fouque D; Soulage CO
    Curr Diab Rep; 2018 Sep; 18(10):97. PubMed ID: 30194541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function.
    Wang Y; Xie Q; Zhang Y; Ma W; Ning K; Xiang JY; Cui J; Xiang H
    Appl Microbiol Biotechnol; 2020 Jan; 104(1):335-349. PubMed ID: 31758237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Streptococcus thermophilus NCIMB 41856 ameliorates signs of colitis in an animal model of inflammatory bowel disease.
    Bailey JR; Vince V; Williams NA; Cogan TA
    Benef Microbes; 2017 Aug; 8(4):605-614. PubMed ID: 28618865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.
    Ceccarelli G; Statzu M; Santinelli L; Pinacchio C; Bitossi C; Cavallari EN; Vullo V; Scagnolari C; d'Ettorre G
    Expert Opin Biol Ther; 2019 Sep; 19(9):949-965. PubMed ID: 31260331
    [No Abstract]   [Full Text] [Related]  

  • 40. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.